PMID- 33711968 OWN - NLM STAT- MEDLINE DCOM- 20210514 LR - 20220531 IS - 1471-2415 (Electronic) IS - 1471-2415 (Linking) VI - 21 IP - 1 DP - 2021 Mar 12 TI - Dynamic monocyte chemoattractant protein-1 level as predictors of perceived pain during first and second phacoemulsification eye surgeries in patients with bilateral cataract. PG - 133 LID - 10.1186/s12886-021-01880-z [doi] LID - 133 AB - BACKGROUND: The purpose of the study was to investigate whether dynamic monocyte chemoattractant protein-1 (MCP-1) level might be as predictors of perceived pain during the first and second phacoemulsification eye surgeries in patients with bilateral cataract. METHODS: Consecutive bilateral cataract patients undergoing bilateral sequential phacoemulsification were retrospectively enrolled. Patients' preoperative anxiety score and intraoperative pain score were registered. Aqueous humor samples were obtained during surgery. MCP-1 level in the aqueous humor was measured by enzyme linked immunosorbent assay (Elisa). Patients were assigned to seven subgroups based on the interval between first-eye and second-eye cataract surgery. Comparisons were performed for a subjective sensation and MCP-1 levels among different subgroups. RESULTS: pain score during second-eye surgery was significantly higher than during first-eye surgery. Whereas there was no statistical difference in anxiety score between both surgeries. Result from subgroups comparison showed that the visual analog scale (VAS) pain score was statistically greater in 1-group and 6-group during the second eye surgery. Anxiety score did not statistically differ in subgroups. Additionally, the second-eye MCP-1 level was significantly higher at week 1and 6 intervals. Preoperative MCP-1 level was positively correlated with perceiving pain score during both surgeries. CONCLUSIONS: MCP-1 level in aqueous humor significantly correlated with perceived pain during cataract surgery. Dynamic MCP-1 level could function as predictors of perceived pain during the first and second phacoemulsification eye surgeries in patients with bilateral cataract, which might support clinicians in treatment optimization and clinical decision-making. FAU - Zhang, Feng AU - Zhang F AD - Department of Ophthalmology, The Second Clinical Medical College, Jing Zhou Central Hospital, Yangtze University, Hubei, 434020, Jing Zhou, China. AD - Department of Cataract, Ophthalmic Center, The Second Affiliated Hospital of Jilin University, Jilin, 130041, Chang Chun, China. FAU - Wang, Jin-Hua AU - Wang JH AD - Department of Ophthalmology, The Second Clinical Medical College, Jing Zhou Central Hospital, Yangtze University, Hubei, 434020, Jing Zhou, China. FAU - Zhao, Mei-Sheng AU - Zhao MS AD - Department of Cataract, Ophthalmic Center, The Second Affiliated Hospital of Jilin University, Jilin, 130041, Chang Chun, China. zhaoms1961@sina.com. LA - eng PT - Journal Article DEP - 20210312 PL - England TA - BMC Ophthalmol JT - BMC ophthalmology JID - 100967802 RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) SB - IM MH - *Cataract/complications MH - Chemokine CCL2/*blood MH - Humans MH - *Pain MH - Pain Measurement MH - Pain Perception MH - Phacoemulsification/*adverse effects MH - Retrospective Studies PMC - PMC7953781 OTO - NOTNLM OT - Bilateral cataract surgery OT - CCL2 OT - MCP-1 OT - Pain OT - Predictor COIS- The authors declare that they have no competing interests. EDAT- 2021/03/14 06:00 MHDA- 2021/05/15 06:00 PMCR- 2021/03/12 CRDT- 2021/03/13 05:27 PHST- 2020/10/07 00:00 [received] PHST- 2021/02/25 00:00 [accepted] PHST- 2021/03/13 05:27 [entrez] PHST- 2021/03/14 06:00 [pubmed] PHST- 2021/05/15 06:00 [medline] PHST- 2021/03/12 00:00 [pmc-release] AID - 10.1186/s12886-021-01880-z [pii] AID - 1880 [pii] AID - 10.1186/s12886-021-01880-z [doi] PST - epublish SO - BMC Ophthalmol. 2021 Mar 12;21(1):133. doi: 10.1186/s12886-021-01880-z.